Abbott agrees collabs with 4 pump providers for hybrid closed loop with combined glucose - ketone sensor
Abbott announced their intention to develop a combined glucose-ketone sensor back in 2022 as according to the company, there is a pressing need for a continuous glucose-ketone monitor for individuals who are at higher risk of developing DKA i.e. diabetic ketoacidosis.
What is a glucose-ketone sensor?
The new type of sensor will both detect and help to prevent DKA by providing wearers with early warnings of raised ketone levels, which can appear before other known symptoms.
Abbott’s sensor will be the same shape and size as the FreeStyle Libre 3/3 Plus.
When will the sensor be available?
A prototype version of the glucose-ketone sensor is already in clinical testing and pivotal trials are scheduled to start next year. It’s likely rollout will be towards the end of 2026, or even 2027.
How will the sensor integrate with pumps?
So far, partnerships with Tandem, Beta Bionics, Sequel MedTech, and Ypsomed have been announced to integrate their pump systems with the new dual sensor and enable Abbott’s sensors to work as part of a hybrid closed loop/AID systems.
How will these systems integrate?
Beta Bionics
The iLet Bionic Pancreas is the first and only AID system that autonomously makes 100% of insulin dosing decisions. This eliminates the need for carb counting or manual insulin correction calculations.
Ypsomed
Ypsomed confirmed they will connect their mylife Loop modular system, with its YpsoPump and the CamAPS FX controlling software to the new glucose-ketone sensor.
Tandem
Tandem will be integrating the t:slim X2 insulin pump featuring Control-IQ+ advanced hybrid closed-loop technology.
Sequel
Sequel’s twist will integrate with Abbott’s new sensor as part of an Automated Insulin Delivery (AID) System powered by Tidepool.
Other Abbott News
Partnership with Medtronic
Back in September 2024 it was revealed that Abbott are to produce a sensor for use with Medtronic insulin systems (as we reported here). The sensor will only be available from Medtronic so won’t be a direct competitor to FreeStyle Libre. No timeline has been given for launch yet.
Epic News!
Meanwhile in the US, Abbott have launched a new universal FreeStyle Libre app and have partnered with Epic EHR to integrate data from FreeStyle Libre (i.e. LibreView) directly into their electronic health record systems. Linking the systems will allow healthcare professionals to see glucose data from FreeStyle Libre devices within Epic and update healthcare records.
Epic is the leading provider of EHR software in the US with over 575,000 healthcare professionals using the systems and covering over 280 million patients.
Disclaimer
Blogs and publications on this website are independent of any involvement by medtech companies or diabetes related charities. To ensure there is no bias, we do not accept any products, freebies or other material from any medtech provider. Except where credited otherwise, all materials are copyright ©️Love My Libre Ltd.
Love My Libre is not associated or affiliated with Abbott or FreeStyle Libre. Content here and on our website www.lovemylibre.com does not constitute medical advice or replace the relationship between you and healthcare professionals nor the advice you receive from them.
The author of this blog has type 1 diabetes and uses the FreeStyle Libre 2 which is provided on NHS prescription.
Leave a comment (all fields required). Please note, we are unable to respond to individual comments posted here.